|Dr. Hartley Atkinson Ph.D.||Co-Founder, CEO, MD & Exec. Director||474.92k||N/A||N/A|
|Ms. Marree Atkinson||Co-Founder, Chief of Staff & Exec. Director||92.66k||N/A||N/A|
|Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ||CFO & Company Sec.||N/A||N/A||N/A|
|Mr. Murray Keith||Group Marketing Mang.||N/A||N/A||N/A|
|Ms. Ioana Stanescu||Head of Drug Devel.||N/A||N/A||N/A|
|Mr. Calvin Mackenzie||Gen. Mang. of AFT Australia||N/A||N/A||N/A|
|Mr. Scott Crawford||Gen. Mang. of Promoted Products Australasia & South East Asia||N/A||N/A||N/A|
|Ms. Louise Clayton||Director of International Bus.||N/A||N/A||N/A|
AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.
AFT Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.